595 research outputs found
3D Reconstruction from IR Thermal Images and Reprojective Evaluations
Infrared thermography has been widely used in various domains to measure the temperature distributions of objects and surfaces. The methodology can be further extended to 3D applications if the spatial information of the temperature distribution is available. This paper proposes a 3D infrared imaging approach based on silhouette volume intersection to reconstruct volumetric temperature data of enclosed objects. 3D IR images are taken from various angles and integrated with 2D RGB images to effectively reconstruct a 3D model of the object's temperature distributions. Various automatic thresholding methods are also compared and evaluated by reprojection scoring to systematically assess the effectiveness and accuracy of the different approaches. Experiment results have demonstrated the ability of the system to provide an estimate to the 3D location of an internal heat source from images taken externally
Evaluating the Effects of an Interdisciplinary Practice Model with Pharmacist Collaboration on HIV Patient Co-Morbidities
Treatment of HIV now occurs largely within the primary care setting, and the principal focus of most visits has become the management of chronic disease states. The clinical pharmacist’s potential role in improving chronic disease outcomes for HIV patients is unknown. A retrospective cohort study was performed for HIV-positive patients also diagnosed with diabetes, hypertension, or hyperlipidemia. Characteristics and outcomes in 96 patients treated by an interdisciplinary team which included a clinical pharmacist (i.e., the intervention group) were compared to those in 50 patients treated by an individual healthcare provider (i.e., the control group). Primary outcomes were changes from baseline over 18 month period of HbA1c, low density lipoprotein (LDL), and blood pressure, respectively. Secondary outcomes included number of drug-drug interactions, HIV viral load, CD4 count, percent change in smoking status, and percent of patients treated to cardiovascular guideline recommendations. The interdisciplinary team had a significant improvement in lipid management over the control group (LDL: -8.8 vs. +8.4 mg/dL; p=0.014), and the smoking cessation rate over the study period was doubled in the interdisciplinary group (20.4% vs. 11.8%). Among those with an indication for aspirin, a significantly higher percentage of patients were prescribed the medication in the interdisciplinary group compared to the control group (85.5% v. 64.9%; p=0.014). An informal cost analysis estimated savings of more than $3000 per patient treated by the interdisciplinary team. Based on these results, pharmacist involvement in an HIV primary care clinic appears to lead to more appropriate management of chronic co-morbidities in a cost-effective manner
Gender Difference of Alanine Aminotransferase Elevation May Be Associated with Higher Hemoglobin Levels among Male Adolescents
BACKGROUND: To explore the gender difference of ALT elevation and its association with high hemoglobin levels. METHODS: A cross-sectional study of 3547 adolescents (2005 females, mean age of 16.5?.3 years) who were negative for hepatitis B surface antigen received health checkups in 2006. Body mass index (BMI), levels of hemoglobin, ALT and cholesterol were measured. ALT >42 U/L was defined as elevated ALT. Elevated ALT levels were detected in 112 of the 3547 participants (3.3%), more prevalent in males than in females (5.4% vs. 1.4%, p<0.001). Hemoglobin levels had a significant linear correlation with ALT levels in both genders. Abnormal ALT started to occur if hemoglobin >11 g/dl in females or >13.5 g/dl in males, but the cumulative cases of elevated ALT increased more quickly in males. Proportion of elevated ALT increased as either the BMI or hemoglobin level rise, more apparent in male adolescents. Logistic regression modeling showed odds ratio (95% confidence interval) were 24.7 (15.0-40.6) for BMI ≥27 kg/m(2); 5.5 (2.9-10.4) for BMI 24-27 kg/m(2); 2.7 (1.3-5.5) for Q5 (top 20th percentile) hemoglobin level; and 2.6 (1.6-4.1) for male gender. Further separately fitting the logistic models for two genders, the significance of Q5 hemoglobin level only appeared in the males. CONCLUSIONS: High hemoglobin level is a significant risk factor of ALT elevation after control hepatitis B, obesity and gender. Males have greater risk of abnormal liver function which may be associated with higher hemoglobin levels
Microcrystalline-Silicon-Oxide-Based N-Type Reflector Structure in Micromorph Tandem Solar Cells
N-type microcrystalline silicon oxide thin films (n-c-SiO:H) have been deposited by VHF-PECVD (40 MHz) with reactant gas mixtures of CO2/SiH4 and H2. N-c-SiO thin films exhibiting low refractive index value (n600nm∼2), and medium/high conductivity (≧10−9 S/cm) are suitable to be used as an “n-type reflector” in micromorph tandem solar cells. Transmission electron microscopy (TEM) results show that microstructures of n-c-SiO:H thin films contain nanocrystalline Si particles, which are randomly embedded in the a-SiO matrix. This specific microstructure provides n-c-SiO:H thin films excellent optoelectronic properties; therefore, n-c-SiO:H thin films are appropriate candidates for “n-type reflector” structures in Si tandem solar cells
Finishing the euchromatic sequence of the human genome
The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead
The Hyper Suprime-Cam SSP survey: Overview and survey design
Hyper Suprime-Cam (HSC) is a wide-field imaging camera on the prime focus of the 8.2-m Subaru telescope on the summit of Mauna Kea in Hawaii. A team of scientists from Japan, Taiwan, and Princeton University is using HSC to carry out a 300-night multi-band imaging survey of the high-latitude sky. The survey includes three layers: the Wide layer will cover 1400 deg2 in five broad bands (grizy), with a 5 σ point-source depth of r ≈ 26. The Deep layer covers a total of 26 deg2 in four fields, going roughly a magnitude fainter, while the UltraDeep layer goes almost a magnitude fainter still in two pointings of HSC (a total of 3.5 deg2). Here we describe the instrument, the science goals of the survey, and the survey strategy and data processing. This paper serves as an introduction to a special issue of the Publications of the Astronomical Society of Japan, which includes a large number of technical and scientific papers describing results from the early phases of this survey
Recommended from our members
Empirical estimates from the 1996-2004 MEPS data and longitudinal projection from Markov modeling
Long-term glucocorticoid use leads to glucocorticoid-induced osteoporosis (GIOP) and fractures which require proper management. Little is known about the "real-world," long-term costs and effectiveness of anti-osteoporotic treatments. A retrospective analysis of data from the 1996-2004 Medical Expenditure Panel Survey was conducted to evaluate the "real-world" outcomes. Markov modeling with Monte Carlo simulations was used to yield long-term estimates of these outcomes. A total of 5,461 subjects met the study criteria for long-term glucocorticoid users (LTGS, average prednisone-equivalent dose=11.0 mg/day, average length=237 days), which represents 2.3% of the non-institutional U.S. population. The study subjects tended to be middle-aged (49.7 years old), female (61.4%) and white (86.2%). Overall 22.4% of LTGS users reported use of any anti-osteoporotic agent. Hormone replacement therapy (HRT) was the most frequently used in women followed by bisphosphonates, while bisphosphonates and calcitonin were used by men. Analyses of variance indicated some significant differences in characteristics of LTGS users among treatment groups which suggest a selection bias. Female LTGS users had higher prevalence rates (6.8%) of osteoporosis than males (1.0%), but the prevalence rates of osteoporotic fractures were similar (3.0%). The logistic regression analyses indicated that the use of oral glucocorticoid tablets does not significantly change the odds of osteoporotic fractures in study subjects (relative risk (RR)=1.146, 95% confidence interval (CI) 0.901-1.458 for subjects in the WELL state; RR=0.55, 95% CI 0.188-1.621 for subjects in the GIOP state; RR=1.241, 95% CI 0.532-2.893 for subjects in the GIFX state). The estimated 10-year and lifetime incremental cost per osteoporotic fracture avoided are 35,692 (10-year) and 91,075 (lifetime) in hypothetical female glucocorticoid users. HRT is the most cost-effective option for hypothetical females except that calcitonin is preferred for 65-year-old females receiving lifetime treatments. When HRT is excluded, calcitonin is the next most cost-effective option except that raloxifene is preferred for 30- and 50-year-old females receiving 10-year treatments. Calcitonin is the most cost-effective option for male glucocorticoid users. Bisphosphonates are less cost-effective which may be due to selection bias. Anti-osteoporotic treatments are recommended for all long-term glucocorticoid users, but the preferred option depends on gender, age, length of treatments and budgets.Pharmac
Recommended from our members
Fluoroquinolone Prophylaxis in Acute Myeloid Leukemia (AML) Patients Undergoing Post-Remission Chemotherapy Reduces Hospital Admission Rates
Abstract
Abstract 2570
Background:
High-dose cytarabine (HIDAC) is a standard treatment for younger AML patients (pts) receiving post-remission chemotherapy. The risk for febrile neutropenia (FN) is high among these pts and considered a medical emergency, requiring prompt hospital admission and treatment. In 2004 our institution adopted the use of fluoroquinolones (FQ) for bacterial prophylaxis in AML pts receiving HIDAC. We compared rates of hospital admission due to FN before and after the initiation of bacterial prophylaxis with FQ. We also evaluated the incidence of blood stream infections (BSI) and the incidence of resistant infections among the two groups.
Methods:
We identified AML (excluding acute promyelocytic leukemia) pts receiving cytarabine-based remission induction chemotherapy at Cleveland Clinic who achieved a complete remission and then were treated with HIDAC post-remission chemotherapy (cytarabine dose of 3000mg/m2 × 6) from 1997–2008. Pts receiving FQ prophylaxis with ciprofloxacin 500mg twice daily or levofloxacin 500mg once daily comprised the treatment group, while AML patients with no prophylaxis served as controls. Pts were excluded if they developed an episode of FN during hospital admission for HIDAC or received non-FQ bacterial prophylaxis. Categorical data and continuous variables were analyzed per chemotherapy cycle using Fishers exact test and independent-sample t-tests, respectively.
Results:
80 pts received HIDAC post-remission chemotherapy during the study period; 52 received FQ prophylaxis; 28 did not. A total of 198 chemotherapy cycles were administered, 148 in the FQ group and 50 in the control group. The mean age (+/−SD) of the entire cohort was 44.8 (11.4) years; 53% were female. Despite the decreased use of granulocyte-colony stimulating factor in the FQ group (12% vs. 50%, p<0.001), the duration of neutropenia was the same (24.6 days vs. 23.8 days, p=0.5) between groups. All other baseline characteristics were similar. FQ treated pts had a 33% absolute reduction in hospital admissions due to FN (50.7% vs. 84%, p<0.001) and when admitted, hospital LOS for FN was shorter for the FQ group (7.9 days vs. 10.5 days, p=0.007). The incidence of BSI was also reduced in the FQ group (23% vs. 42%, p=0.009); however there was an increase in resistant gram-negative (5/17 vs. 0/14, p=0.04) and resistant gram-positive (15/19 vs. 3/9, p=0.03) infections among pts treated with FQ.
Conclusion:
AML pts treated with HIDAC chemotherapy followed by FQ prophylaxis had fewer and shorter hospital admissions due to FN compared to pts with no prophylaxis. FQ treated patients were at increased risk of developing antibiotic-resistant bacterial BSI.
Disclosures:
No relevant conflicts of interest to declare
- …